Skip to main content
  • Meeting abstract
  • Open access
  • Published:

Androgen-sensitive hypertension associated with soluble guanylate cyclase alpha1 deficiency is mediated by 20-HETE


Dysregulated nitric oxide (NO) signaling contributes to the pathogenesis of hypertension. Previously, we reported gender- and strain-specific hypertension in mice deficient in the α1-subunit of the NO receptor soluble guanylate cyclase (sGCα1-/-): male mice on an Sv129/J (S6) but not a C57BL6/J (B6) background are hypertensive.

Methods and results

Via linkage analysis, we identified a quantitative trait locus (QTL) associated with elevated blood pressure in male sGCα1-/-S6 mice. This QTL encompasses CYP4a12a, encoding the predominant murine synthase of the vasoconstrictor 20-hydroxyeicosatetraenoic acid (20-HETE). Renal expression of CYP4a12awas strain-, gender-, and testosterone-dependent:CYP4a12a gene expression was higher in male WT and sGCα1-/-S6 mice than in female S6 mice, or than in male and female, WT and sGCα1-/- B6 mice, higher in testosterone-treated S6 mice than in vehicle-treated S6 mice, and higher in sham-operated S6 mice than orchiectomized S6 mice. Also, 20-HETE levels were higher in renal preglomerular microvessels of male sGCα1-/- S6 than of sGCα1-/- B6 mice. Furthermore, the 20-HETE antagonist 20-6,15-HEDGE lowered blood pressure in male sGCα1-/- S6 but not WT mice. Finally, the more significant impairment of acetylcholine-induced relaxation of renal interlobar arteries in male sGCα1-/- S6 than sGCα1-/- B6 mice, in male sGCα1-/- S6 than WT S6 mice, and in male sham-operated sGCα1-/- S6 mice than orchiectomized sGCα1-/- S6 mice was rescued by 20-6,15-HEDGE.


Gender- and strain-specific hypertension and vascular dysfunction in sGCα1-/- S6 mice is associated with elevated CYP4a12a expression and 20-HETE levels, and is abrogated by antagonizing 20-HETE. These results corroborate our hypothesis that testosterone-induced CYP4a12a expression and a concomitant increase in 20-HETE production contribute to the hypertension associated with impaired NO-cGMP signaling and that CYP4a12a represents a candidate blood pressure modifying gene in the context of deficient NO-sGC signaling.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Emmanuel S Buys.

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit

The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vandenwijngaert, S., Dordea, A.C., Garcia, V. et al. Androgen-sensitive hypertension associated with soluble guanylate cyclase alpha1 deficiency is mediated by 20-HETE. BMC Pharmacol Toxicol 16 (Suppl 1), A97 (2015).

Download citation

  • Published:

  • DOI: